Yuning Cheng

Yuning Cheng

Auto-generated profile, based on publicly available information

Yuning Cheng

Laboratory of Bone Tissue Engineering, Beijing Laboratory of Biomedical Materials, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Oncogenesis
Verified
Journal Article
Open access
PDF file
YLYujuan Liu
Yujuan Liu
JWJiyin Wang
Jiyin Wang
RYRuixiang Yang
Ruixiang Yang
YCYuning Cheng
Yuning Cheng
YZYue Zhou
Yue Zhou
XZXiaowei Zhang
Xiaowei Zhang
Golgi protein 73 (GP73) and alpha fetoprotein (AFP) serve as biomarkers for the diagnosis of hepatocellular carcinoma (HCC), and their serum levels correlate with patients’ outcomes. However, the mechanisms underlying these correlations are unknown. Here we show that GP73 increased the secretion of AFP through direct binding to AFP, thereby promoting the proliferation and metastasis of HCC cells that expressed AFP and its receptor (AFPR). Extracellular GP73 contributed to the proliferation and metastasis of HCC cells independent of AFP and AFPR. Moreover, extracellular AFP and GP73 synergized to enhance the malignant phenotype of HCC cells. Furthermore, extracellular GP73 and AFP inhibited the antitumor effects of sorafenib and synergistically increased the drug resistance of HCC cells. These findings, which reveal the mechanism of GP73-mediated secretion of AFP and its effects on the malignant phenotype of HCC cells, provide a comprehensive theoretical basis for the diagnosis and treatment of HCC and identify potential drug targets.

8 August 2022 in Oncogenesis
Verified
Journal Article
Open access
PDF file
JWJiyin Wang
Jiyin Wang
RYRuixiang Yang
Ruixiang Yang
YCYuning Cheng
Yuning Cheng
YZYue Zhou
Yue Zhou
TZTongjia Zhang
Tongjia Zhang
XZXiaowei Zhang
Xiaowei Zhang
HBP1 is a sequence-specific transcription factor which generally considered as a crucial growth inhibitor. Posttranslational modification of HBP1 is vital for its function. In this study, we demonstrate that HBP1 is methylated at R378 by PRMT1, which decreases HBP1 protein stability by promoting its ubiquitination and proteasome-mediated degradation. PRMT1-mediated methylation of HBP1 alleviates the repressive effects of HBP1 on tumor metastasis and growth. GSN is identified as a novel target gene of HBP1. Methylation of HBP1 promotes actin cytoskeleton remodeling, glycolysis and tumor progression by downregulating GSN (a vital actin-binding protein) levels. The methylated HBP1-GSN axis is associated with the clinical outcomes of cancer patients. This investigation elucidates the mechanism of how methylated HBP1 facilitates actin cytoskeleton remodeling, thus attenuates its tumor-suppressive function and promotes tumor progression. Targeting methylated HBP1-GSN axis may provide a therapeutic strategy for cancer.

1 August 2024 in Bioactive Materials
Verified
Journal Article
Open access
JNJing-Jum Nie
Jing-Jum Nie
BZBowen Zhang
Bowen Zhang
PLPeng Luo
Peng Luo
MLMaoguo Luo
Maoguo Luo
YLYuwen Luo
Yuwen Luo
Dafu ChenDafu Chen
Dafu Chen
Osteosarcoma is the most common malignant bone tumor without efficient management for improving 5-year event-free survival. Immunotherapy is also limited due to its highly immunosuppressive tumor microenvironment (TME). Pore-forming gasdermins (GSDMs)-mediated pyroptosis has gained increasing concern in reshaping TME, however, the expressions and relationships of GSDMs with osteosarcoma remain unclear. Herein, gasdermin E (GSDME) expression is found to be positively correlated with the prognosis and immune infiltration of osteosarcoma patients, and low GSDME expression was observed. A vector termed as LPAD contains abundant hydroxyl groups for hydrating layer formation was then prepared to deliver the GSDME gene to upregulate protein expression in osteosarcoma for efficient TME reshaping via enhanced pyroptosis induction. Atomistic molecular dynamics simulations analysis proved that the hydroxyl groups increased LPAD hydration abilities by enhancing coulombic interaction. The upregulated GSDME expression together with cleaved caspase-3 provided impressive pyroptosis induction. The pyroptosis further initiated proinflammatory cytokines release, increased immune cell infiltration, activated adaptive immune responses and create a favorable immunogenic hot TME. The study not only confirms the role of GSDME in the immune infiltration and prognosis of osteosarcoma, but also provides a promising strategy for the inhibition of osteosarcoma by pore-forming GSDME gene delivery induced enhanced pyroptosis to reshape the TME of osteosarcoma.

15 June 2026 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
NZNan Zhang
Nan Zhang
YLYuwen Luo
Yuwen Luo
PLPeng Luo
Peng Luo
JCJiarui Cao
Jiarui Cao
YCYuning Cheng
Yuning Cheng
Dafu ChenDafu Chen
Dafu Chen
Bone regeneration assisted by synthetic bone substitutes largely depends on the integration of the vascular, neural, and lymphatic systems in the bone. Bone marrow mesenchymal stem cells (BMSCs) are the key cells for this process. However, their role in regulating the integration has not been fully characterized. Human BMSCs (hBMSCs) were treated with osteogenic induction and collected from 0 to 504 h for bulk RNA sequencing (RNA-Seq). Differentially expressed genes (DEGs) were identified and Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Time-Series Transcriptomic Trend Analysis were used to comprehensively analyze the possible pathways and functions associated with these DEGs. Weighted Gene Co-expression Network Analysis (WGCNA) was constructed to identify the modules and hub genes of the process. Quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) were performed to validate the expression of key genes identified by RNA-Seq. Time-series analysis of the hBMSCs transcriptome suggested a dynamic expression trajectory during osteogenic differentiation, which was characterized by four functional patterns: the initial adaptation stage (1-24 h), the proliferation activation stage (24-72 h), the differentiation regulation stage (72-336 h) and the remodeling stability stage (336-504 h). Moreover, 72 h was suggested as a potential key time point in the osteogenic-vascular-neural-lymphatic coupling process based on transcriptomic analysis, with typical activation of BMP, vascular endothelial growth factor (VEGF) and PPAR signaling pathways. Four modules and closely related hub genes such as growth differentiation factor 5 (GDF5), matrix Gla protein (MGP) and pregnancy-associated plasma protein A2 (PAPPA2), whose expressions were validated by qRT-PCR and ELISA were also identified and highlighted. Our study revealed the temporal trends of angiogenesis, lymphangiogenesis, and neurogenesis during BMSCs osteogenic differentiation, which not only supplemented the transcriptional regulation in bone regeneration, but also provided a theoretical basis for the design of synthetic bone substitutes.

22 August 2026 in Advanced Functional Materials
Verified
Journal Article
Closed access
PLPeng Luo
Peng Luo
JCJiarui Cao
Jiarui Cao
BZBowen Zhang
Bowen Zhang
YLYuwen Luo
Yuwen Luo
NZNan Zhang
Nan Zhang
Dafu ChenDafu Chen
Dafu Chen